SCHEMBL7798884

SCHEMBL7798884

COc1ccc(C(=O)NC(CSSCC(NC(=O)c2ccc(OC)cc2)C(=O)NCCc2ccccc2)C(=O)NCCc2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
CTSS P25774 5/20 0.55
CTSK P43235 4/20 0.55
CTSL P07711 3/20 0.54
KMT2A Q03164 1/20 0.54
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
GAA P10253 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.52
MAPT P10636 2/20 0.52
PLAAT3 P53816 1/20 0.50
PLAAT5 Q96KN8 1/20 0.50
PLAAT2 Q9NWW9 1/20 0.50
PLAAT4 Q9UL19 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793390 0.88 KMT2A (0.57) ALDH1A1CTSSCTSKCTSLKMT2A
SCHEMBL7798889 0.87 NPC1 (0.64) CTSSCTSKCTSLKMT2ANPC1
SCHEMBL7799255 0.85 L3MBTL1 (0.50) CTSLKMT2ANPC1RAB9AGAA
SCHEMBL7798890 0.83 NPC1 (0.48) ALDH1A1CTSSCTSKCTSLKMT2A
SCHEMBL2247378 0.81 ADAMTS5 (0.59) ALDH1A1CTSSCTSKCTSLKMT2A
SCHEMBL2247765 0.81 ADAMTS5 (0.59) ALDH1A1CTSSCTSKCTSLKMT2A
SCHEMBL7705937 0.80 ALDH1A1 (0.76) ALDH1A1KMT2ANPC1RAB9AGAA
SCHEMBL7793435 0.80 CA12 (0.52) ALDH1A1CTSSCTSKKMT2ASMN1; SMN2
SCHEMBL2247441 0.78 CTSS (0.52) ALDH1A1CTSSCTSKCTSLNPC1
SCHEMBL5534162 0.78 CTSL (0.58) CTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed